How were new medicines discovered?
The DOI matches its Crossref record; 171 of the 173 references it cites were found in a registry or an index.
Abstract
Preclinical strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biologic-based approaches. To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analysed the discovery strategies and the molecular mechanism of action (MMOA) for new molecular entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008. Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small molecules and 25 (33%) were biologics. The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-molecule drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, respectively - in an era in which the major focus was on target-based approaches. We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are two main advantages of the phenotypic screening method for identifying covalent PPI inhibitors. Firstly, this technique identifies cell-active compounds directly. Secondly, the biological target does not have to be known before screening [81].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [81]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Research works printed but not linked: 3
- Cuppoletti J. et al. Recombinant and native intestinal cell ClC-2 Cl− channels are activated by RU-0211. Gastroenterology 122, A538 (2002).
- Stein, R. L., Ma, Y. T. & Brand, S. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein. US Patent 5,693,617 (1995).
- Mendel, D. B. et al. In vivo anti-tumor activity of SU11248, a novel tyrosine kinase inhibitor targeting VEGF and PDGF receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin. Cancer Res. 9, 327–337 (2003).
Cited by
Items 801–900 of 1,000
Modeling timelines for translational science in cancer; the impact of technological maturation
McNamee, L. M., & Ledley, F. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174538 · Cited by 21
Link between a high k on for drug binding and a fast clinical action: to be or not to be?
Vauquelin, G. (2018) · MedChemComm · doi:10.1039/c8md00296g · Cited by 23
Neri, F. S. M., Costa, D. B., Froes, T. Q., da Silva, P. B. G., do Egito, M. S., Moreira, P. O. L., Varotti, F. D. P., Castilho, M. S., Teixeira‐Neto, R. G., de Albuquerque, J. F. C., et al. (2020) · Parasitology Research · doi:10.1007/s00436-020-06706-3 · Cited by 19
New Small Molecules Targeting Apoptosis and Cell Viability in Osteosarcoma
Maugg, D., Rothenaigner, I., Schorpp, K., Potukuchi, H. K., Korsching, E., Baumhoer, D., Hadian, K., Smida, J., & Nathrath, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129058 · Cited by 20
Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods
Ekins, S., Litterman, N. K., Lipinski, C. A., & Bunin, B. A. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1779-y · Cited by 19
The development of acamprosate as a treatment against alcohol relapse
Kufahl, P. R., Watterson, L. R., & Olive, M. F. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.960840 · Cited by 21
G-protein-coupled receptor regulation ofde novopurine biosynthesis: a novel druggable mechanism
Ye, F., French, J. B., Zhao, H., & Benkovic, S. J. (2013) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2013.801237 · Cited by 21
Addressing the Right Targets in Oncology: Challenges and Alternative Approaches
Stock, J. K., Jones, N. P., Hammonds, T. R., Roffey, J., & Dillon, C. (2015) · SLAS DISCOVERY · doi:10.1177/1087057114564349 · Cited by 21
Mueller, C., Kremb, S., Gonsior, M. J., Brack‐Werner, R., Voolstra, C. R., & Schmitt‐Kopplin, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-57709-0 · Cited by 20
Xing, J., Tan, M., Leshchiner, D. R., Sun, M., Abdelgied, M., Huang, L., Paithankar, S., Uhl, K. L., Shankar, R., Lisabeth, E. M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.016 · Cited by 20
Wride, D. A., Pourmand, N., Bray, W. M., Kosarchuk, J. J., Nisam, S. C., Quan, T. K., Berkeley, R. F., Katzman, S. J., Hartzog, G. A., Dobkin, C., et al. (2014) · Molecular BioSystems · doi:10.1039/c4mb00146j · Cited by 18
Ghosh, S. K., Ganta, A., & Spanjaard, R. A. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0408-6 · Cited by 18
Target Identification Approaches in Drug Discovery
Rasul, A., Riaz, A., Sarfraz, I., Khan, S. G., Hussain, G., Zara, R., Sadiqa, A., Bushra, G., Riaz, S., Iqbal, M. J., et al. (2022) · Computer-aided drug discovery and design · doi:10.1007/978-3-030-95895-4_3 · Cited by 21
A comprehensive review on potential candidates for the treatment of chagas disease
Pathak, S., Bhardwaj, M., Agrawal, N., & Bhardwaj, A. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14257 · Cited by 18
Bridging the gap between target-based and phenotypic-based drug discovery
Calado, C. R. C. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2355330 · Cited by 22
Flickinger, K. M., Wilson, K. M., Rossiter, N. J., Hunger, A. L., Vishwasrao, P., Lee, T. D., Fritz, C. M., Richards, R. M., Hall, M. D., & Cantor, J. R. (2024) · Science Advances · doi:10.1126/sciadv.adq3591 · Cited by 19
Segmenting the Etiological Agent of Schistosomiasis for High-Content Screening
Asarnow, D. E., & Singh, R. (2013) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2013.2247412 · Cited by 18
Zebrafish Models of Kidney Damage and Repair
Cirio, M. C., de Caestecker, M. P., & Hukriede, N. A. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0080-4 · Cited by 22
Swinney, Z., Haubrich, B. A., Xia, S., Ramesha, C. S., Gomez, S. R., Guyett, P. J., Mensa‐Wilmot, K., & Swinney, D. C. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004506 · Cited by 20
Self-citationPaunovic, A., Drowley, L., Nordqvist, A., Ericson, E., Mouchet, E., Jonebring, A., Grönberg, G., Kvist, A. J., Engkvist, O., Brown, M. R., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00683 · Cited by 18
Contreras‐Baeza, Y., Ceballo, S., Arce‐Molina, R., Sandoval, P. Y., Alegría, K., Barros, L. F., & Martín, A. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224527 · Cited by 19
Deep Learning-Based Morphological Classification of Endoplasmic Reticulum Under Stress
Guo, Y., Shen, D., Zhou, Y., Yang, Y., Liang, J. Q., Zhou, Y., Li, N., Liu, Y., Yang, G., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.767866 · Cited by 20
Puentes, P. R., Rueda-Gensini, L., Valderrama, N., Hernández, I., González, C., Daza, L. A., Muñoz-Camargo, C., Cruz, J. C., & Arbeláez, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-12180-x · Cited by 20
Mazzoleni, S., Cartenì, F., Bonanomi, G., Incerti, G., Chiusano, M. L., Termolino, P., Migliozzi, A., Senatore, M., Giannino, F., Rietkerk, M., et al. (2014) · Phytochemistry Reviews · doi:10.1007/s11101-014-9386-9 · Cited by 19
Profiling of Small Molecules by Chemical Proteomics
Huber, K., & Superti‐Furga, G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3341-9_15 · Cited by 18
Small zebrafish in a big chemical pond
Helenius, I. T., & Yeh, J.-R. J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24120 · Cited by 17
Meyer‐Almes, F. (2015) · European Biophysics Journal · doi:10.1007/s00249-015-1090-1 · Cited by 17
Digles, D., Zdrazil, B., Neefs, J., van Vlijmen, H., Herhaus, C., Caracoti, A., Brea, J. M., Roibás, B., Loza, M. I., Queralt-Rosiñach, N., et al. (2016) · MedChemComm · doi:10.1039/c6md00065g · Cited by 18
Large-Scale Functional Genomics Screen to Identify Modulators of Human β-Cell Insulin Secretion
Szczerbinska, I., Tessitore, A., Hansson, L., Agrawal, A., Lopez, A. R., Helenius, M., Malinowski, A. R., Gilboa, B., Ruby, M. A., Gupta, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10010103 · Cited by 20
Dechering, K. J., Timmerman, M., Rensen, K., Koolen, K. M. J., Honarnejad, S., Vos, M. W., Huijs, T. T. G., Henderson, R., Chenu, E., Laleu, B., et al. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2022.07.002 · Cited by 17
Yang, Z., Liu, J., Zhu, X., Yang, F., Zhang, Q., & Shah, H. A. (2022) · Frontiers of Computer Science · doi:10.1007/s11704-022-2163-9 · Cited by 17
Woodland, A., Thompson, S., Cleghorn, L. A. T., Norcross, N. R., Rycker, M. D., Grimaldi, R., Hallyburton, I., Rao, B., Norval, S., Stojanovski, L., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500300 · Cited by 17
O’Sullivan, D., Henry, M. A., Joyce, H., Walsh, N., Auley, E. M., Dowling, P., Swan, N., Moriarty, M. J., Barnham, P., CLYNES, M. M., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-1857-5 · Cited by 20
Novel approaches in antimalarial drug discovery
Held, J., Kreidenweiss, A., & Mordmüller, B. G. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.843522 · Cited by 17
Grasela, T. H., & Slusser, R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.242 · Cited by 17
Knight, S., Plant, H., McWilliams, L. J., Murray, D., Dixon-Steele, R., Varghese, A., Harper, P., Ramne, A., McArdle, P., Engberg, S., et al. (2017) · SLAS DISCOVERY · doi:10.1177/2472555216683650 · Cited by 17
Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis
Quan, D. H., Nagalingam, G., Luck, I. J., Proschogo, N. W., Pillalamarri, V., Addlagatta, A., Martínez, E., Sintchenko, V., Rutledge, P. J., & Triccas, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50748-2 · Cited by 17
Deep Learning-Based HCS Image Analysis for the Enterprise
Steigele, S., Siegismund, D., Faessler, M., Kustec, M., Kappler, B., Hasaka, T., Yee, A. X., Brodte, A., & Heyse, S. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220918837 · Cited by 17
Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
Valli, D., Gruszka, A., & Alcalay, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061892 · Cited by 19
Miyajima, R., Sakai, K., Otani, Y., Wadatsu, T., Sakata, Y., Nishikawa, Y., Tanaka, M., Yamashita, Y., Hayashi, M., Kondo, K., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00335 · Cited by 17
Pharmacognosy and Its Role in the System of Profile Disciplines in Pharmacy
Cahlíková, L., Šafratová, M., Hošťálková, A., Chlebek, J., Hulcová, D., Breiterová, K., & Opletal, L. (2020) · Natural Product Communications · doi:10.1177/1934578x20945450 · Cited by 17
Chakraborty, S., Gourain, V., Benz, M., Scheiger, J. M., Levkin, P. A., & Popova, A. A. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100112 · Cited by 19
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development
Aldrich, J. V., & McLaughlin, J. P. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_519 · Cited by 17
Lecca, D., Hsueh, S., Luo, W., Tweedie, D., Kim, D. S., Baig, A. M., Vargesson, N., Kim, Y. K., Hwang, I., Kim, S., et al. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00907-5 · Cited by 17
Combined Analysis of Phenotypic and Target-Based Screening in Assay Networks
Swamidass, S. J., Schillebeeckx, C., Matlock, M. K., Hurle, M. R., & Agarwal, P. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114523068 · Cited by 17
Karlsson, R., Fridh, V., & Frostell, Å. (2017) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2017.12.008 · Cited by 17
Preformulation in Drug Research and Pharmaceutical Product Development
Acharya, P. C., Shetty, S. R., Fernandes, C., Suares, D., Maheshwari, R., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814423-7.00001-0 · Cited by 26
Meng, L., Sun, C., Zhang, C., Song, S., Sun, X., Ju, J., & Deng, Y. (2019) · Marine Drugs · doi:10.3390/md17080442 · Cited by 18
Twarog, N. R., Low, J. A., Currier, D. G., Miller, G., Chen, T., & Shelat, A. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149439 · Cited by 16
A Knowledge‐Guided Graph Learning Approach Bridging Phenotype‐ and Target‐Based Drug Discovery
Ye, Q., Zeng, Y., Jiang, L., Kang, Y., Pan, P., Chen, J., Deng, Y., Zhao, H., He, S., Hou, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202412402 · Cited by 22
The Life Sciences Translational Challenge: The European Perspective
Barker, R., & Scannell, J. W. (2014) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479014561340 · Cited by 18
Lü, Y., Boswell, W. T., Boswell, M., Klotz, B. J., Kneitz, S., Regneri, J., Savage, M. G., Mendoza, C., Postlethwait, J. H., Warren, W. C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36656-x · Cited by 19
Bai, Q., Shao, E., Ma, D., Jiao, B., Scheetz, S. D., Hartnett, K. A., Ильин, В. Н., Aizenman, E., Kofler, J., & Burton, E. A. (2024) · Nature Communications · doi:10.1038/s41467-024-52173-0 · Cited by 20
Structural enrichment of HTS compounds from available commercial libraries
Petrova, T., Chuprina, A., Parkesh, R., & Pushechnikov, A. O. (2012) · MedChemComm · doi:10.1039/c2md00302c · Cited by 16
Geerts, H., & Kennis, L. E. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.97 · Cited by 16
Yang, T., He, H., Ang, W., Yang, Y., Yang, J., Lin, Y., Yang, H.-C., Pi, W., Li, Z., Zhao, Y., et al. (2012) · Molecules · doi:10.3390/molecules17032351 · Cited by 16
Laraia, L., Stokes, J. E., Emery, A., McKenzie, G. J., Venkitaraman, A. R., & Spring, D. R. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5000564 · Cited by 16
Oeljeklaus, J., Kaschani, F., & Kaiser, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201207306 · Cited by 16
Liu, Y., Platchek, M., Kement, B., Bee, W. T., Truong, M., Zeng, X., Hung, S., Lin, H., Morrow, D. M., Kallal, L. A., et al. (2013) · Molecular BioSystems · doi:10.1039/c3mb70413k · Cited by 17
Beierlein, J. M., McNamee, L. M., Walsh, M. J., & Ledley, F. D. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.07.003 · Cited by 18
Facile One-Pot Parallel Synthesis of 3-Amino-1,2,4-triazoles
Bogolyubsky, A. V., Savych, O., Zhemera, A. V., Pipko, S. E., Grishchenko, A. V., Konovets, A. I., Doroshchuk, R. O., Khomenko, D. M., Броварец, В. С., Moroz, Y. S., et al. (2018) · ACS Combinatorial Science · doi:10.1021/acscombsci.8b00060 · Cited by 16
Ljungars, A., Mårtensson, L., Mattsson, J. S. M., Kovacek, M., Sundberg, A., Tornberg, U.-C., Jansson, B., Persson, N., Emruli, V. K., Ek, S., et al. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0061-2 · Cited by 16
Ramu, D., Jain, R., Kumar, R. R., Sharma, V., Garg, S., Ayana, R., Luthra, T., Yadav, P., Sen, S., & Singh, S. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201800290 · Cited by 16
Yang, S., Shen, Y., Lu, W., Yang, Y., Wang, H., Li, L., Wu, C., & Du, G. (2019) · BioMed Research International · doi:10.1155/2019/6847685 · Cited by 17
Latest trends in structure based drug design with protein targets
Bagchi, A. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.11.008 · Cited by 19
Single-cell infrared phenomics: phenotypic screening with infrared microspectroscopy
Wang, Y., Wang, Y., Qian, J., Pan, X., Li, X., Chen, F., Hu, J., & Lü, J. (2020) · Chemical Communications · doi:10.1039/d0cc05721e · Cited by 16
Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development
Lin, X., Tang, J., & Lou, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14060525 · Cited by 18
Network Pharmacology and Traditional Chinese Medicine
Xu, Q., Qu, F., & Pelkone, O. (2012) · InTech eBooks · doi:10.5772/53868 · Cited by 19
Shao, L., Campbell, U. C., Fang, Q. K., Powell, N. A., Campbell, J. E., JONES, P. G., Hanania, T., Alexandrov, V., Morganstern, I., Sabath, E. V., et al. (2016) · MedChemComm · doi:10.1039/c6md00128a · Cited by 16
A Phenotarget Approach for Identifying an Alkaloid Interacting with the Tuberculosis Protein Rv1466
Xie, Y., Feng, Y., Capua, A. D., Mak, T., Buchko, G. W., Myler, P. J., Liu, M., & Quinn, R. J. (2020) · Marine Drugs · doi:10.3390/md18030149 · Cited by 16
The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery
Yuan, T., Werman, J. M., & Sampson, N. S. (2021) · RSC Chemical Biology · doi:10.1039/d0cb00226g · Cited by 16
Oligodendrocyte N-Methyl-d-aspartate Receptor Signaling: Insights into Its Functions
Cao, N., & Yao, Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8408-8 · Cited by 19
Yun, C., Li, N., Zhang, Y., Fang, T., Ma, J., Zheng, Z., Zhou, S. H., & Cai, X. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00584 · Cited by 17
Burt, T., Roffel, A. F., Langer, O., Anderson, K., & DiMasi, J. A. (2022) · Clinical and Translational Science · doi:10.1111/cts.13269 · Cited by 16
Green, K. D., Pang, A. H., Chandrika, N. T., Garzan, A., Baughn, A. D., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00450 · Cited by 15
Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present)
Gu, Z., Yan, Y., Yao, H., Lin, K., & Li, X. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2130753 · Cited by 16
Advancements in Drug Repurposing: Examples in Psychiatric Medications
Okuyama, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311000 · Cited by 15
Finding new analgesics: Computational pharmacology faces drug discovery challenges
Barakat, A., Munro, G., & Heegaard, A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116091 · Cited by 16
Zhao, Z., Haynes, M. K., Ursu, O., Edwards, B. S., Sklar, L. A., & Zweifach, A. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114557620 · Cited by 15
The Use of Antibodies in Small-Molecule Drug Discovery
Marsden, C. J., Eckersley, S., Hebditch, M., Kvist, A. J., Milner, R. D. B., Mitchell, D., Warwicker, J., & Marley, A. E. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114527770 · Cited by 17
Creating Decision Trees to Assess Cost-Effectiveness in Clinical Research
Werner, E. F. (2012) · Journal of Biometrics & Biostatistics · doi:10.4172/2155-6180.s7-004 · Cited by 15
Sato, Y., Tateno, H., Adachi, J., Okuyama, H., Endo, H., Tomonaga, T., & Inoue, M. (2016) · Scientific Reports · doi:10.1038/srep24823 · Cited by 15
Pries, V., Cotesta, S., Riedl, R., Aust, T., Schuierer, S., Tao, J., Filipuzzi, I., & Hoepfner, D. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115610488 · Cited by 18
Phenotypic screening meets natural products in drug discovery†
Futamura, Y., Yamamoto, K., & Osada, H. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1248365 · Cited by 15
Ding, M., Brengdahl, J., Lindqvist, M., Gehrmann, U., Ericson, E., von Berg, S., Ripa, L., & Malhotra, R. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00075 · Cited by 16
Meanwell, N. A., & Belema, M. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2018_47 · Cited by 15
Fostering practice-oriented and use-inspired science in biomedical research
Anckaert, P., Cassiman, D. M., & Cassiman, B. (2019) · Research Policy · doi:10.1016/j.respol.2019.103900 · Cited by 18
State-of-the-Art Technology of Model Organisms for Current Human Medicine
Konno, M., Asai, A., Kitagawa, T., Yabumoto, M., Ofusa, K., Arai, T., Hirotsu, T., Doki, Y., Eguchi, H., & Ishii, H. (2020) · Diagnostics · doi:10.3390/diagnostics10060392 · Cited by 17
Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase
Williams, N. S., Gonzales, S. S., Naidoo, J., Rivera‐Cancel, G., Voruganti, S., Mallipeddi, P. L., Theodoropoulos, P. C., Geboers, S., Chen, H., Ortiz, F., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00899 · Cited by 15
Lv, S., Chen, Q., Li, Z., & Zhou, Z. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174094 · Cited by 15
Huang, F., Zeng, Z., Zhang, W., Yan, Z., Chen, J., Yu, L., Yang, Q., Li, Y., Yu, H., Chen, J., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113542 · Cited by 15
Diversity-oriented synthesis encoded by deoxyoligonucleotides
Hudson, L., Mason, J. W., Westphal, M. V., Richter, M. J. R., Thielman, J. R., Hua, B. K., Gerry, C. J., Xia, G., Osswald, H. L., Knapp, J. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40575-5 · Cited by 15
Structure–Activity Studies of Divin: An Inhibitor of Bacterial Cell Division
Zhou, M., Eun, Y.-J., Guzei, I. A., & Weibel, D. B. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400234x · Cited by 15
Arshad, M., Goller, C., Pilla, D. M., Schoenen, F. J., & Seed, P. C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv584 · Cited by 17
High content analysis in amyotrophic lateral sclerosis
Rinaldi, F., Motti, D., Ferraiuolo, L., & Kaspar, B. K. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.001 · Cited by 17
CHEMGENIE: integration of chemogenomics data for applications in chemical biology
Kutchukian, P. S., Chang, C., Fox, S., Cook, E. M., Barnard, R., Tellers, D. M., Wang, H., Pertusi, D. A., Glick, M., Sheridan, R. P., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.004 · Cited by 15
Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening
Nickischer, D. R., Elkin, L. L., Cloutier, N. J., O’Connell, J. C., Banks, M. N., & Weston, A. D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7357-6_11 · Cited by 15
Stimulation of alpha2-adrenergic receptors impairs influenza virus infection
Matsui, K., Ozawa, M., Kiso, M., Yamashita, M., Maekawa, T., Kubota, M., Sugano, S., & Kawaoka, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-22927-0 · Cited by 18
Computational Drug Repurposing for Neurodegenerative Diseases
Savva, K., Zachariou, M., Oulas, A., Minadakis, G., Sokratous, K., Dietis, N., & Spyrou, G. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00004-3 · Cited by 15
Kannan, R. R., Iniyan, A. M., & Vincent, S. G. P. (2014) · Europe PMC (PubMed Central) · Cited by 15
Metadata
- Authors
- Swinney, D. C., & Anthony, J.
- Corresponding author
- Swinney, David C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-06-24
- Volume
- 10
- Issue
- 7
- Pages
- 507-519
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2052214665
- Cited by
- 1,812
- References
- 173
- Citations by year
- 2026: 80 · 2025: 73 · 2024: 102 · 2023: 86 · 2022: 96 · 2021: 109 · 2020: 127 · 2019: 129 · 2018: 113 · 2017: 136 · 2016: 160 · 2015: 170 · 2014: 157 · 2013: 137 · 2012: 115
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Keywords
- drug discovery strategies, phenotypic screening, target-based screening, molecular mechanisms of action, first-in-class drugs, new chemical entities, small molecule drugs, drug attrition, FDA-approved drugs
- MeSH terms
- Pharmacological Phenomena, Drug Industry, Drug Evaluation, Preclinical, Humans, United States, United States Food and Drug Administration, Drug Design, Drug Approval, Drug Discovery, Molecular Targeted Therapy, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.